Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Class action filed
Acq. announced
Consulting agrmnt
Quarterly results
Director departure
Appointed director
CC transcript
|
|
ERESEARCHTECHNOLOGY INC (ERES)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/11/2013 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/08/2012 |
SC 13G/A
| ERESEARCHTECHNOLOGY INC reports a |
| 07/13/2012 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 07/13/2012 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 07/13/2012 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 07/09/2012 |
8-K
| Quarterly results |
| 07/09/2012 |
8-K
| Entered into consulting agreement|
Docs:
|
"Agreement and Plan of Merger, by and among invivodata, Inc., Explorer Holdings, Inc., eResearchTechnology, Inc. (as successor to Explorer Acquisition Corp.), Impact Acquisition Corp. and Fortis Advisors LLC",
"Amended and Restated Certificate of Incorporation of eResearchTechnology, Inc",
"Amended and Restated Bylaws of eResearchTechnology, Inc",
"Genstar Capital Completes ERT Acquisition In A Take-Private Transaction PHILADELPHIA, July 3, 2012/PRNewswire/—ERT , a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations , announced today that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction valued at approximately $400 million. Dr. Jeffrey Litwin, who will continue to lead ERT as CEO, said, “As a private company we will continue to serve our customers and enhance our suite of products. We have been able to grow our company into a global leader, and, with Genstar's partnership, we will look for creative new ways to grow our business organically and identify new investment opportunities as part of our continued develo...",
"ERT Acquires invivodata to Establish the Industry's Most Experienced Provider of Clinical Outcome Assessment Solutions PHILADELPHIA, PA, July 9 2012 /PRNewswire/ - ERT, a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and Contract Research Organizations , announced today the acquisition of invivodata, Inc, a leading provider of electronic Patient Reported Outcomes solutions and PRO Consulting services, based in Pittsburgh, PA. The transaction was facilitated by the San Francisco-based private equity group, Genstar Capital, LLC who last week announced that they had completed the acquisition of ERT. The acquisition immediately positions ERT as a leader in Clinical Outcome Assessments . The combined organization will now offer sponsors, CROs and ot..." |
|
| 07/06/2012 |
4
| Scheppmann Stephen Mark (Director) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/|
Txns:
| Disposed/sold 9,643 shares
@ $8, valued at
$77.1k
Disposed/sold 10,870 options to buy
@ $6.21, valued at
$67.5k
Disposed/sold 9,212 options to buy
@ $7.37, valued at
$67.9k
Disposed/sold 22,000 options to buy
@ $4.6, valued at
$101.2k
|
|
| 07/06/2012 |
4
| SCHNECK KEITH D (Exec VP, CFO & Secretary) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/|
Txns:
| Disposed/sold 19,045 shares
@ $0
Disposed/sold 34,968 shares
@ $8, valued at
$279.7k
Disposed/sold 38,835 options to buy
@ $6.46, valued at
$250.9k
Disposed/sold 38,759 options to buy
@ $6.05, valued at
$234.5k
Disposed/sold 75,000 options to buy
@ $4.6, valued at
$345k
|
|
| 07/06/2012 |
4
| PHILLIPS STEPHENS S (Director) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/|
Txns:
| Disposed/sold 193,503 shares
@ $8, valued at
$1.5M
Disposed/sold 10,870 options to buy
@ $6.21, valued at
$67.5k
Disposed/sold 9,212 options to buy
@ $7.37, valued at
$67.9k
Disposed/sold 22,000 options to buy
@ $4.6, valued at
$101.2k
Disposed/sold 45,000 options to buy
@ $6.29, valued at
$283.1k
|
|
| 07/06/2012 |
4
| MORGANROTH JOEL M D (Exec VP, Chief Scientific Off) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/|
Txns:
| Disposed/sold 19,068 shares
@ $0
Disposed/sold 1,258,974 shares
@ $8, valued at
$10.1M
Disposed/sold 80,097 options to buy
@ $6.46, valued at
$517.4k
Disposed/sold 43,253 options to buy
@ $6.05, valued at
$261.7k
Disposed/sold 70,000 options to buy
@ $4.6, valued at
$322k
Disposed/sold 30,000 options to buy
@ $7.41, valued at
$222.3k
Disposed/sold 90,000 options to buy
@ $6.29, valued at
$566.1k
|
|
| 07/06/2012 |
4
| HITCHNER ELAM M III (Director) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/|
Txns:
| Disposed/sold 17,143 shares
@ $8, valued at
$137.1k
Disposed/sold 10,870 options to buy
@ $6.21, valued at
$67.5k
Disposed/sold 9,212 options to buy
@ $7.37, valued at
$67.9k
Disposed/sold 22,000 options to buy
@ $4.6, valued at
$101.2k
|
|
| 07/06/2012 |
4
| FAICH GERALD A (Director) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/|
Txns:
| Disposed/sold 41,643 shares
@ $8, valued at
$333.1k
Disposed/sold 10,870 options to buy
@ $6.21, valued at
$67.5k
Disposed/sold 9,212 options to buy
@ $7.37, valued at
$67.9k
|
|
| 07/06/2012 |
4
| Besier Klaus P (Director) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/|
Txns:
| Disposed/sold 10,570 shares
@ $8, valued at
$84.6k
Disposed/sold 10,870 options to buy
@ $6.21, valued at
$67.5k
Disposed/sold 11,130 options to buy
@ $6.09, valued at
$67.8k
|
|
| 07/06/2012 |
4
| LITWIN JEFFREY S (President & CEO) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/|
Txns:
| Disposed/sold 43,644 shares
@ $0
Disposed/sold 192,947 shares
@ $8, valued at
$1.5M
Disposed/sold 31,327 options to buy
@ $6.21, valued at
$194.5k
Disposed/sold 35,437 options to buy
@ $6.46, valued at
$228.9k
Disposed/sold 36,456 options to buy
@ $6.05, valued at
$220.6k
Disposed/sold 50,000 options to buy
@ $4.6, valued at
$230k
Disposed/sold 20,000 options to buy
@ $7.41, valued at
$148.2k
Disposed/sold 52,500 options to buy
@ $6.29, valued at
$330.2k
|
|
| 07/06/2012 |
4
| Schuelke Achim (Exec VP, Chief Technology Off) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/|
Txns:
| Disposed/sold 14,760 shares
@ $0
Disposed/sold 1,979 shares
@ $8, valued at
$15.8k
Disposed/sold 10,797 shares
@ $8, valued at
$86.4k
Disposed/sold 50,097 options to buy
@ $6.46, valued at
$323.6k
Disposed/sold 75,000 options to buy
@ $7.94, valued at
$595.5k
|
|
| 07/06/2012 |
4
| FURLONG AMY (Exec VP, Chief Operations Off) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/|
Txns:
| Disposed/sold 16,188 shares
@ $0
Disposed/sold 7,380 shares
@ $8, valued at
$59k
Disposed/sold 19,031 shares
@ $8, valued at
$152.2k
Disposed/sold 33,010 options to buy
@ $6.46, valued at
$213.2k
Disposed/sold 30,104 options to buy
@ $6.05, valued at
$182.1k
Disposed/sold 50,000 options to buy
@ $4.6, valued at
$230k
Disposed/sold 20,000 options to buy
@ $7.41, valued at
$148.2k
Disposed/sold 11,250 options to buy
@ $6.29, valued at
$70.8k
Disposed/sold 5,625 options to buy
@ $3.01, valued at
$16.9k
|
|
| 07/06/2012 |
4
| DEVINE THOMAS P (Exec VP, Chief Information Off) has filed a Form 4 on ERESEARCHTECHNOLOGY INC /DE/|
Txns:
| Disposed/sold 15,474 shares
@ $0
Disposed/sold 10,000 shares
@ $8, valued at
$80k
Disposed/sold 24,740 shares
@ $8, valued at
$197.9k
Disposed/sold 31,553 options to buy
@ $6.46, valued at
$203.8k
Disposed/sold 28,547 options to buy
@ $6.05, valued at
$172.7k
Disposed/sold 50,000 options to buy
@ $4.6, valued at
$230k
Disposed/sold 20,000 options to buy
@ $7.41, valued at
$148.2k
Disposed/sold 43,688 options to buy
@ $6.29, valued at
$274.8k
Disposed/sold 17,375 options to buy
@ $4.21, valued at
$73.1k
|
|
| 07/03/2012 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 07/03/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/03/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/03/2012 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 07/03/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/03/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/03/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 07/03/2012 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 06/12/2012 |
8-K
| Class action lawsuit filed |
| 05/21/2012 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
| 05/07/2012 |
10-Q
| Quarterly Report for the period ended March 31, 2012 |
| 05/07/2012 |
8-K
| Quarterly results |
| 05/04/2012 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 04/30/2012 |
10-K/A
| Annual Report for the period ended December 31, 2011 [amend] |
| 04/11/2012 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 04/10/2012 |
8-K
| Form 8-K - Current report |
|
|
|